Parosmia Beyond Olfactory Loss: A Propensity Score-Matched Study of Central Sensitization-Associated Comorbidities. [PDF]
Amidor E +8 more
europepmc +1 more source
Effectiveness and Safety of Low-Sodium Oxybate in Participants with Idiopathic Hypersomnia: Primary Results from the DUET Study. [PDF]
Plante DT +10 more
europepmc +1 more source
Quality of life in Australian patients with central disorders of hypersomnolence. [PDF]
Kinder S, Winter S, Duce B, Ellender CM.
europepmc +1 more source
Novel 3‑Heteroaryl Pyrrolidine and Piperidine Compounds as Orexin Receptor Agonists for Treating Sleep Disorders, namely, Narcolepsy and Hypersomnia. [PDF]
Sabnis RW.
europepmc +1 more source
A Sleep and Circadian Biomarker-Based Predictive Model for Differentiating Unipolar and Bipolar Depression. [PDF]
Leseur J +8 more
europepmc +1 more source
Association between sleep inertia and cognitive performance among older adults in the Wisconsin Sleep Cohort study. [PDF]
Love JJ +7 more
europepmc +1 more source
Vagus Nerve Stimulation for Sleep Disorders: Emerging Evidence and Future Directions. [PDF]
Wang X +5 more
europepmc +1 more source
Anti-Ma2 Encephalitis as a Treatable Cause of Narcolepsy Type 1: A Case Report. [PDF]
Wang M, Zhang N, Bian Z, Li Y, Wang S.
europepmc +1 more source
The Sleep Symptoms Are Directly Associated With Suicide Risk in Adolescents and Youth Patients With Depression. [PDF]
Zheng Y, Yuan S, Zhang J, Ma Y, He H.
europepmc +1 more source
Idiopathic hypersomnia is a 24-hour disorder. [PDF]
Foldvary-Schaefer N +3 more
europepmc +1 more source

